Login / Signup

Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.

Ahmad Aizat Abdul AzizMd Salzihan Md SallehMaya Mazuwin YahyaAndee Dzulkarnaen ZakariaRavindran Ankathil
Published in: Asian Pacific journal of cancer prevention : APJCP (2021)
Our results demonstrate the potential use of CYP1B1 4325 GG variant genotype as a candidate biomarker in predicting risk of recurrence in TNBC patients undergoing TAC chemotherapy regimen.
Keyphrases
  • free survival
  • patients undergoing
  • locally advanced
  • genome wide
  • squamous cell carcinoma
  • copy number
  • radiation therapy
  • rectal cancer
  • climate change